Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)

3 Months Ended

Mar. 31, 2013

Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities

Schedule of marketable investment securities, restricted cash and other investment securities

	As of
	March 31,		December 31,
	2013		2012
	(In thousands)
Marketable investment securities:
Current marketable investment securities - VRDNs	$	123,976	$	130,306
Current marketable investment securities - strategic	1,350,173		1,261,015
Current marketable investment securities - other	2,690,079		2,240,316
Total current marketable investment securities	4,164,228		3,631,637
Restricted marketable investment securities (1)	64,059		51,366
Noncurrent marketable investment securities - ARS and other (2)	112,474		106,172
Total marketable investment securities	4,340,761		3,789,175
Restricted cash and cash equivalents (1)	26,918		83,044
Other investment securities:
Other investment securities - cost method (2)	12,879		12,879
Total other investment securities	12,879		12,879
Total marketable investment securities, restricted cash and cash equivalents and other investment securities	$	4,380,558	$	3,885,098

(1) Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash and marketable investment securities” on our Condensed Consolidated Balance Sheets.

(2) Noncurrent marketable investment securities — auction rate securities (“ARS”) and other investment securities are included in “Marketable and other investment securities” on our Condensed Consolidated Balance Sheets.

Schedule of unrealized gain (loss) on marketable investment securities

	As of March 31, 2013										As of December 31, 2012
	Marketable										Marketable
	Investment		Unrealized								Investment		Unrealized
	Securities		Gains		Losses			Net			Securities		Gains		Losses			Net
	(In thousands)
Debt securities:
VRDNs	$	123,976	$	—	$	—		$	—		$	130,306	$	—	$	—		$	—
ARS and other	45,957		1,156		(5,370		)	(4,214		)	43,921		1,375		(8,033		)	(6,658		)
ARS fair value election	66,517		—		—			—			62,251		—		—			—
Other (including restricted)	3,748,615		203,257		(1,036		)	202,221			3,287,317		208,208		(1,203		)	207,005
Equity securities	355,696		38,789		(10,923		)	27,866			265,380		17,918		(11,537		)	6,381
Total	$	4,340,761	$	243,202	$	(17,329	)	$	225,873		$	3,789,175	$	227,501	$	(20,773	)	$	206,728

Schedule of available-for-sale securities in continuous unrealized loss position by length of time and their fair value

	As of
	March 31, 2013					December 31, 2012
	Fair		Unrealized			Fair		Unrealized
	Value		Loss			Value		Loss
	(In thousands)
Debt Securities:
Less than 12 months	$	1,213,859	$	(734	)	$	761,551	$	(909	)
12 months or more	51,534		(5,672		)	72,395		(8,327		)
Equity Securities:
Less than 12 months	57,164		(10,923		)	154,566		(11,537		)
12 months or more	—		—			—		—
Total	$	1,322,557	$	(17,329	)	$	988,512	$	(20,773	)

Schedule of fair value measurements

	As of
	March 31, 2013								December 31, 2012
	Total		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3
	(In thousands)
Cash equivalents (including restricted)	$	2,533,492	$	4,336	$	2,529,156	$	—	$	3,386,929	$	67,833	$	3,319,096	$	—
Debt securities:
VRDNs	$	123,976	$	—	$	123,976	$	—	$	130,306	$	—	$	130,306	$	—
ARS and other	112,474		—		871		111,603		106,172		—		955		105,217
Other (including restricted)	3,748,615		11,115		3,737,500		—		3,287,317		11,182		3,276,135		—
Equity securities	355,696		355,696		—		—		265,380		265,380		—		—
Subtotal	4,340,761		366,811		3,862,347		111,603		3,789,175		276,562		3,407,396		105,217
Purchases and prepaid funding of derivative financial instruments	558,358		209,034		349,324		—		—		—		—		—
Total	$	4,899,119	$	575,845	$	4,211,671	$	111,603	$	3,789,175	$	276,562	$	3,407,396	$	105,217

Schedule of changes in Level 3 instruments

	Level 3
	Investment
	Securities
	(In thousands)
Balance as of December 31, 2012	$	105,217
Net realized and unrealized gains (losses) included in earnings	4,296
Net realized and unrealized gains (losses) included in other comprehensive income (loss)	2,526
Purchases	—
Settlements	(436		)
Issuances	—
Transfers from level 2 to level 3	—
Balance as of March 31, 2013	$	111,603

Schedule of gains and losses on sales and changes in carrying values of investments

	For the Three Months
	Ended March 31,
Other Income (Expense):	2013			2012
	(In thousands)
Marketable investment securities - gains (losses) on sales/exchanges	$	557		$	4,619
Marketable investment securities - unrealized gains (losses) on investments accounted for at fair value	4,266			8,479
Marketable investment securities - gains (losses) on conversion of DBSD North America Notes (1)	—			99,445
Derivative financial instruments - unrealized gains (losses)	8,358			—
Marketable investment securities - other-than-temporary impairments	(1,919		)	(2,481		)
Other	(1,522		)	220
Total	$	9,740		$	110,282

(1) During the three months ended March 31, 2012, we recognized a $99 million non-cash gain related to the conversion of our DBSD North America 7.5% Convertible Senior Secured Notes due 2009 in connection with the completion of the DBSD Transaction.